HA
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
7.845
Exchange
XNAS - Nasdaq
7.1
Last period Current ratio
140%
Current ratio has increased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Halozyme
Company Analysis
HALO valuation, rating, competitors, insights and company profile
Eyestock Rating
HALO financial analysis by Eyestock methodology
Valuation
HALO valuation using historical relative method
Statements
HALO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
HALO dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Halozyme`s Current ratio for the last twelve months ended 2024-06-30 is 7.1
